ELLIPSES Trademark

Trademark Overview


On Tuesday, August 17, 2021, a trademark application was filed for ELLIPSES with the United States Patent and Trademark Office. The USPTO has given the ELLIPSES trademark a serial number of 90886631. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, November 25, 2022. This trademark is owned by Ellipses Pharma Ltd. The ELLIPSES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer; veterinary preparations for the treatment of cancer; dietetic preparations for medical purposes; dietetic foods for use in clinical nutrition; food supplements; nutraceuticals for therapeutic and medical purposes; medicated food supplements; biological preparations for the treatment of cancer; anti-cancer preparations; anti-cancer drugs being preparations; compounds for treating cancer being pharmaceutical preparations; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, ...

Medical and pharmacological research services; biological research; clinical research in the field of oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and surgery in relation to cancer; medical research; providing an online network environment for research and development for drug and pharmaceutical development; providing an online network environment for the design, development and testing of drugs and pharmaceuticals; Providing scientific and technological services and research, analysis, and design relating thereto; design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; laboratory research into new drugs and pharmaceutical products; pharmaceutical drug development services; research relating into medicines; consultancy services relating to scientific and medical research; expert advice relat...
ellipses

General Information


Serial Number90886631
Word MarkELLIPSES
Filing DateTuesday, August 17, 2021
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, November 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; veterinary preparations for the treatment of cancer; dietetic preparations for medical purposes; dietetic foods for use in clinical nutrition; food supplements; nutraceuticals for therapeutic and medical purposes; medicated food supplements; biological preparations for the treatment of cancer; anti-cancer preparations; anti-cancer drugs being preparations; compounds for treating cancer being pharmaceutical preparations; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
Goods and ServicesMedical and pharmacological research services; biological research; clinical research in the field of oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and surgery in relation to cancer; medical research; providing an online network environment for research and development for drug and pharmaceutical development; providing an online network environment for the design, development and testing of drugs and pharmaceuticals; Providing scientific and technological services and research, analysis, and design relating thereto; design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; laboratory research into new drugs and pharmaceutical products; pharmaceutical drug development services; research relating into medicines; consultancy services relating to scientific and medical research; expert advice relating to drug development, being consulting services in the field of pharmaceutical research; laboratory analysis in the field of pharmaceutical research; computer hardware and software design and development in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; computer network services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software hosting services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software as a service in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; Information Technology (IT) consultancy, advisory and information services relating to a network of medical research professionals; scientific advisory services; scientific research projects and studies being scientific research and development; conducting clinical trials being scientific and medical research for others; scientific and medical clinical research for others; clinical research for cancer treatments and pharmaceuticals; providing an online network environment for clinical trials; conducting and collating a research network for treatment, cure and prevention of cancer being medical and scientific research; development of measuring and testing methods being research and development in the field of pharmaceuticals; quality control of services; evaluation of drug development services; industrial testing, namely, industrial design services; pharmaceutical product evaluation; testing of chemicals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEllipses Pharma Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon W1J8LG
GB

Trademark Events


Event DateEvent Description
Monday, May 23, 2022NON-FINAL ACTION WRITTEN
Friday, August 20, 2021NEW APPLICATION ENTERED
Tuesday, October 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Monday, May 23, 2022NON-FINAL ACTION E-MAILED
Monday, May 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 25, 2022SUSPENSION LETTER WRITTEN
Friday, November 25, 2022LETTER OF SUSPENSION E-MAILED
Friday, November 25, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 7, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 8, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, December 29, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, June 8, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION